Inventor
SPIEGEL DAVID
US29 patents
⚠️ This page may combine multiple inventors who share the name “SPIEGEL DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV YALE
23 patentsUS10066026B2Sep 4, 2018
Chimeric small molecules for the recruitment of antibodies to cancer cells
UNIV YALE11 citations92
US9556167B2Jan 31, 2017
TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
UNIV YALE22 citations92
US9296708B2Mar 29, 2016
Chimeric small molecules for the recruitment of antibodies to cancer cells
UNIV YALE17 citations92
US11725064B2Aug 15, 2023
Chimeric small molecules for the recruitment of antibodies to cancer cells
UNIV YALE6 citations85
US11014992B2May 25, 2021
Chimeric small molecules for the recruitment of antibodies to cancer cells
UNIV YALE8 citations83
US10703823B2Jul 7, 2020
Chimeric small molecules for the recruitment of antibodies to cancer cells
UNIV YALE9 citations83
US10016412B2Jul 10, 2018
TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
UNIV YALE6 citations82
US10703743B2Jul 7, 2020
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
UNIV YALE1 citations73
US10030008B2Jul 24, 2018
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
UNIV YALE2 citations73
US12083181B2Sep 10, 2024
Bi-functional molecules to degrade circulating proteins
UNIV YALE4 citations72
US11767301B2Sep 26, 2023
Bi-functional molecules to degrade circulating proteins
UNIV YALE4 citations72
US12485178B2Dec 2, 2025
Bifunctional small molecules to target the selective degradation of circulating proteins
UNIV YALE1 citations62
US12084517B2Sep 10, 2024
Chimeric small molecules for the recruitment of antibodies to cancer cells
UNIV YALE0 citations62
US11858917B2Jan 2, 2024
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
UNIV YALE0 citations62
US11136316B2Oct 5, 2021
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the Human Immunodeficiency Virus
UNIV YALE0 citations62
US10188727B2Jan 29, 2019
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
UNIV YALE0 citations52
US12364766B2Jul 22, 2025
Bifunctional small molecules to target the selective degradation of circulating proteins
UNIV YALE0 citations50
US12234256B2Feb 25, 2025
Molecular degraders of extracellular proteins
UNIV YALE0 citations44
US12128105B2Oct 29, 2024
Molecular degraders of extracellular proteins
UNIV YALE0 citations44
US9745334B2Aug 29, 2017
Cytotoxic-drug delivering molecules targeting HIV (CDM-Hs), cytotoxic activity against the human immunodeficiency virus and methods of use
UNIV YALE0 citations41
US10780084B2Sep 22, 2020
Antibody-recruiting molecules for the treatment of cancer
UNIV YALE0 citations38
US10633374B2Apr 28, 2020
Small molecule based antibody-recruiting compounds for cancer treatment
UNIV YALE0 citations33
US10526339B2Jan 7, 2020
Substituted glucosepanes and compositions thereof
UNIV YALE0 citations30
SPIEGEL DAVID
5 patentsUS8852630B2Oct 7, 2014
Chimeric small molecules for the recruitment of antibodies to cancer cells
SPIEGEL DAVID52 citations96
US8859509B2Oct 14, 2014
Chimeric small molecules for the recruitment of antibodies to cancer cells
SPIEGEL DAVID49 citations93
US9562038B2Feb 7, 2017
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
SPIEGEL DAVID5 citations83
US9181224B2Nov 10, 2015
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
SPIEGEL DAVID11 citations83
US9622469B2Apr 18, 2017
Crosslink breakers for preservation of biological substances
SPIEGEL DAVID0 citations41